This is what Novo's logo looks like after they changed their name and turned the bull around a few weeks ago. (Archive photo). Photo: Tom Little/Reuters
Novo inks billion kroner deal for experimental Chinese weight-loss pill
Danish pharmaceutical company Novo has secured rights in most of the world to develop, produce and sell an experimental weight-loss pill from Chinese company Jiangsu Hengrui Pharmaceuticals.
Novo announced the licensing agreement Tuesday. The deal is worth up to 2.6 billion dollars, equivalent...
Get full access to Danish News in English
Gain exclusive access to daily news updates in English pertaining to Denmark with a Ritzau News subscription.
Already a subscriber?